3D Systems Reports Fourth Quarter and Full Year 2024 Financial Results
ROCK HILL, S.C., March 26, 2025 (GLOBE NEWSWIRE) — 3D Systems Corporation (NYSE:DDD) announced today its financial results for the fourth […]
Crane NXT Announces Dates for First Quarter 2025 Earnings Release and Earnings Call
WALTHAM, Mass., March 26, 2025 (GLOBE NEWSWIRE) — Crane NXT, Co. (NYSE: CXT), a premier industrial technology company, today announced […]
Concentrix Reports First Quarter 2025 Results
Exceeds first quarter revenue and profit guidance Reiterates full year guidance and remains on track to generate approximately $625 million […]
Perspective Therapeutics Provides Recent Business Highlights and Reports Full Year 2024 Results
On track for multiple clinical updates through mid-2026, including further progress from two ongoing clinical programs and initiation of therapeutic […]
Cornish Metals Closes Final Tranche of Fundraising and Appoints Mr. James Whiteside to the Board of Directors
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR […]
GameStop Announces Proposed Private Offering of $1.3 Billion of Convertible Senior Notes
GRAPEVINE, Texas, March 26, 2025 (GLOBE NEWSWIRE) — GameStop Corp. (NYSE: GME) (“GameStop”) today announced that it intends to offer, […]
Candel Therapeutics Reports Both Prolonged Median Overall Survival and Long Tail of Survival in Phase 2a Clinical Trial of CAN-2409 in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Non-Responsive to Immune Checkpoint Inhibitor (ICI) Treatment
Experimental treatment with CAN-2409 was associated with a median overall survival (mOS) of 24.5 months in patients with advanced NSCLC […]
Dyadic Reports 2024 Year-End Financial Results and Business Updates
Strong revenue performance, including approximately $1.9 million milestone and license revenue recognized in 2024 Up to $7.5 million in grants […]
HeartCore Establishes New Business Development Team to Further Expand its CMS Business
NEW YORK and TOKYO, March 26, 2025 (GLOBE NEWSWIRE) — HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or “the Company”), a […]
Zentalis Pharmaceuticals Reports Full Year 2024 Financial Results and Operational Updates
Positive azenosertib clinical data demonstrated clinically meaningful results in patients with Cyclin E1+ platinum-resistant ovarian cancer (PROC) Topline data from […]
